title: Uterine cancer, mutational phenotype, and the era of immune checkpoint blockade.
authors.affiliation: a Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences , University of Maryland School of Medicine , Baltimore , MD , USA.
authors.forename: Dana M
authors.initials: DM
authors.lastname: Roque
authors.affiliation: b Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences , Yale University , New Haven , CT , USA.
authors.forename: Alessandro D
authors.initials: AD
authors.lastname: Santin
mesh_terms: D000818:Animals; D059447:Cell Cycle Checkpoints / Q000235:genetics / Q000276:immunology; D005260:Female; D006801:Humans; D009154:Mutation; D014594:Uterine Neoplasms / Q000235:genetics* / Q000276:immunology* / Q000473:pathology / Q000628:therapy*
keywords: Uterine cancer; immune checkpoint blockade; mutational phenotype